Cargando…
Geniposide Protects against Obesity-Related Cardiac Injury through AMPKα- and Sirt1-Dependent Mechanisms
Our previous study found that geniposide, an agonist of glucagon-like peptide-1 receptor (GLP-1R), protected against cardiac hypertrophy via the activation of AMP-activated protein kinase α (AMPKα). However, the effects of geniposide on obesity-related cardiac injury remain unknown. Here, we examine...
Autores principales: | Ma, Zhen-Guo, Kong, Chun-Yan, Song, Peng, Zhang, Xin, Yuan, Yu-Pei, Tang, Qi-Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247476/ https://www.ncbi.nlm.nih.gov/pubmed/30533173 http://dx.doi.org/10.1155/2018/6053727 |
Ejemplares similares
-
Protection against Doxorubicin-Induced Cytotoxicity by Geniposide Involves AMPKα Signaling Pathway
por: Meng, Yan-Yan, et al.
Publicado: (2019) -
Geniposide Alleviates Isoproterenol-Induced Cardiac Fibrosis Partially via SIRT1 Activation in vivo and in vitro
por: Li, Ning, et al.
Publicado: (2018) -
Protective Effects of Geniposide and Genipin against Hepatic Ischemia/Reperfusion Injury in Mice
por: Kim, Joonki, et al.
Publicado: (2013) -
Remote ischemic preconditioning protects against spinal cord ischemia–reperfusion injury in mice by activating NMDAR/AMPK/PGC-1α/SIRT3 signaling
por: Gu, Changjiang, et al.
Publicado: (2023) -
Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway
por: Ma, Zhen-Guo, et al.
Publicado: (2016)